Enzalutamide and Vibramycin (Doxycycline) 100 mg (Vibramycin 100 mg): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Enzalutamide induction of CYP and other metabolic pathways can reduce the partner medicine’s exposure and effect.
Clinical significance and safety
With Enzalutamide and Vibramycin (Doxycycline) 100 mg, the partner medicine may become less effective. The enzalutamide product information names the relevant medicine or drug class among potential induction-related interactions. Review is important when enzalutamide is started, changed or stopped, because induction can persist after stopping it. The clinician should monitor the treatment response and make any adjustment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.